Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2005 5
2006 4
2007 4
2008 7
2009 6
2010 13
2011 14
2012 18
2013 15
2014 10
2015 6
2016 5
2017 1
2018 5
2019 6
2020 13
2021 8
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean doyen oh (12 results)?
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
Updated recommendations for the treatment of venous thromboembolism.
Hong J, Ahn SY, Lee YJ, Lee JH, Han JW, Kim KH, Yhim HY, Nam SH, Kim HJ, Song J, Kim SH, Bang SM, Kim JS, Mun YC, Bae SH, Kim HK, Jang S, Park R, Choi HS, Kim I, Oh D; Korean Society of Hematology Thrombosis and Hemostasis Working Party. Hong J, et al. Among authors: oh d. Blood Res. 2021 Mar 31;56(1):6-16. doi: 10.5045/br.2021.2020083. Blood Res. 2021. PMID: 33627521 Free PMC article. Review.
Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.
Lee H, Kang E, Kang HG, Kim YH, Kim JS, Kim HJ, Moon KC, Ban TH, Oh SW, Jo SK, Cho H, Choi BS, Hong J, Cheong HI, Oh D. Lee H, et al. Among authors: oh d. Korean J Intern Med. 2020 Jan;35(1):25-40. doi: 10.3904/kjim.2019.388. Epub 2020 Jan 2. Korean J Intern Med. 2020. PMID: 31935318 Free PMC article. Review.
Clinical history of cancer-associated splanchnic vein thrombosis.
Valeriani E, Di Nisio M, Riva N, Caiano LM, Porreca E, Bang SM, Beyer-Westendorf J, Sartori MT, Barillari G, Santoro R, Kamphuisen PW, Alatri A, Malato A, Vidili G, Oh D, Schulman S, Ageno W; International Registry on Splanchnic Vein Thrombosis (IRSVT) study group. Valeriani E, et al. Among authors: oh d. J Thromb Haemost. 2021 Apr;19(4):983-991. doi: 10.1111/jth.15214. Epub 2021 Feb 24. J Thromb Haemost. 2021. PMID: 33306241 Free article.
Clinical dissection of thrombotic microangiopathy.
Kang E, Yoo SH, Oh D, Joo KW, Kim YS, Yoon SS, Kim I, Park S, Lee H, Koh Y. Kang E, et al. Among authors: oh d. Ann Hematol. 2017 Oct;96(10):1715-1726. doi: 10.1007/s00277-017-3063-1. Epub 2017 Jul 27. Ann Hematol. 2017. PMID: 28752391
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults.
Barbour T, Scully M, Ariceta G, Cataland S, Garlo K, Heyne N, Luque Y, Menne J, Miyakawa Y, Yoon SS, Kavanagh D; 311 Study Group Members. Barbour T, et al. Kidney Int Rep. 2021 Mar 24;6(6):1603-1613. doi: 10.1016/j.ekir.2021.03.884. eCollection 2021 Jun. Kidney Int Rep. 2021. PMID: 34169200 Free PMC article.
Current status of the Korean venous thromboembolism registry.
Oh D; Venous Thromboembolism Working Party of Korean Society of Hematology/Korean Society of Thrombosis and Hemostasis. Oh D, et al. Yonsei Med J. 2011 Jul;52(4):558-61. doi: 10.3349/ymj.2011.52.4.558. Yonsei Med J. 2011. PMID: 21623595 Free PMC article. Review.
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia.
Park YH, Kim DY, Mun YC, Cho EK, Lee JH, Jo DY, Kim I, Yoon SS, Park SY, Kim B, Bang SM, Kim H, Min YJ, Park JH, Seo JJ, Moon HN, Lee MH, Kim CS, Lee WS, Chong SY, Oh D, Zang DY, Lee KH, Hyun MS, Kim HS, Kim SH, Kwon H, Kim HJ, Park KT, Bae SH, Ryoo HM, Choi JH, Ahn MJ, Yoon HJ, Nam SH, Kim BS, Seong CM. Park YH, et al. Among authors: oh d. Korean J Intern Med. 2022 Jul;37(4):841-850. doi: 10.3904/kjim.2021.468. Epub 2022 Jun 28. Korean J Intern Med. 2022. PMID: 35811370 Free PMC article.
126 results